IKS014 in Advanced Solid Tumors That Express HER2
מצבים רפואיים
Breast Cancer · Gastric Cancer · Gastroesophageal-junction Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Contact: Principal Investigator (Monica Mita, MD)Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Nancy Lin, MD)Tennessee Oncology, Nashville, Tennessee, United States
Contact: Principal Investigator (Jeffrey Russell, MD)START Dallas - Fort Worth, Fort Worth, Texas, United States
Contact: Principal Investigator (Henry Xiong, MD)Concord Repatriation General Hospital Medical Oncology Clinical Trials Unit, Concord, New South Wales, Australia
Contact: Principal Investigator (Tam Bui, MD)Macquarie University, Sydney, New South Wales, Australia
Contact: Principal Investigator (Dhanusha Sabanathan, MD)Westmead Hospital, Westmead, New South Wales, Australia
Contact: Principal Investigator (Adnan Nagrial, MD)Peninsula & South Eastern Haematology and Oncology Group (PSEHOG), Frankston, Victoria, Australia
Contact: Principal Investigator (Vinod Ganju, MD)Alfred Health, Melbourne, Victoria, Australia
Contact: Principal Investigator (Malaka Ameratunga, MD)Linear Clinical Research, Nedlands, Western Australia, Australia
Contact: Principal Investigator (Peter Lau, MD)Auckland City Hospital, Auckland, New Zealand
Contact: Principal Investigator (Jane So, MBChB)National Cancer Centre Singapore, Singapore, Singapore
Contact: Principal Investigator (Jing Ying Tira Tan, MBBS)Tan Tock Seng Hospital, Singapore, Singapore
Contact: Principal Investigator (Yue Ming Valerie Heong, MBBS)
מובילי המחקר
James O'Leary, MD
Study Director
Iksuda Therapeutics